Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure

被引：20
作者：
Nathwani, Nitya [1 ]
Krishnan, Amrita Y. [1 ]
Huang, Qin [2 ]
Kim, Young [2 ]
Karanes, Chatchada [1 ]
Smith, Eileen P. [1 ]
Forman, Stephen J. [1 ]
Sievers, Eric [3 ]
Thomas, Sandra H. [1 ]
Chen, Robert W. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol HCT, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA
[3] Seattle Genet, Bothell, WA USA
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 10期
关键词：
STEM-CELL TRANSPLANTATION; DISEASE; TUBULIN; TRIAL;
D O I：
10.3109/10428194.2012.666543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2051 / 2053
页数：3
相关论文
共 14 条
  • [1] Fludarabine-meiphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated MD Anderson Cancer Center experience
    Anderlini, Paolo
    Saliba, Rima
    Acholonu, Sandra
    Giralt, Sergio A.
    Andersson, Borje
    Ueno, Naoto T.
    Hosing, Chitra
    Khouri, Issa F.
    Couriel, Daniel
    de Lima, Marcos
    Qazilbash, Muzaffar H.
    Pro, Barbara
    Romaguera, Jorge
    Fayad, Luis
    Hagemeister, Frederick
    Younes, Anas
    Munsell, Mark F.
    Champlin, Richard E.
    [J]. HAEMATOLOGICA, 2008, 93 (02) : 257 - 264
  • [2] Chen R, 2011, J CLIN ONCOL S, V29
  • [3] Chen R, 2010, BLOOD S1, V116
  • [4] Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma
    Chen, Robert
    Palmer, Joycelynne M.
    Popplewell, Leslie
    Shen, Jessica
    Smith, Eileen
    Delioukina, Maria
    Kogut, Neil
    Rosenthal, Joseph
    Forman, Stephen
    Nademanee, Auayporn
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (07) : 803 - 808
  • [5] FALINI B, 1995, BLOOD, V85, P1
  • [6] Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin
    Gan, Pei Pei
    McCarroll, Joshua A.
    Po'uha, Sela T.
    Kamath, Kathy
    Jordan, Mary Ann
    Kavallaris, Maria
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1339 - 1348
  • [7] Ghetie MA, 1999, CLIN CANCER RES, V5, P3920
  • [8] Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)
    Johnson, PWM
    Radford, JA
    Cullen, MH
    Sydes, MR
    Walewski, J
    Jack, AS
    MacLennan, KA
    Stenning, SP
    Clawson, S
    Smith, P
    Ryder, D
    Hancock, BW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9208 - 9218
  • [9] Microtubules and resistance to tubulin-binding agents
    Kavallaris, Maria
    [J]. NATURE REVIEWS CANCER, 2010, 10 (03) : 194 - 204
  • [10] A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
    Moskowitz, CH
    Nimer, SD
    Zelenetz, AD
    Trippett, T
    Hedrick, EE
    Filippa, D
    Louie, D
    Gonzales, M
    Walits, J
    Coady-Lyons, N
    Qin, J
    Frank, R
    Bertino, JR
    Coy, A
    Noy, A
    O'Brien, JP
    Straus, D
    Portlock, CS
    Yahalom, J
    [J]. BLOOD, 2001, 97 (03) : 616 - 623
12